Olpasiran prescreen study

A Multicenter, Cross-sectional Study to Characterize the Distribution of Lipoprotein(a) Levels Among Patients With Documented History of Atherosclerotic Cardiovascular Disease

Stage
klaar
Medicine
Pre-screening Lp(a)
Population
ASCVD
Phase
Pre-screen
First Patient In
4 August 2022
Last Patient In
9 May 2023
Last Patient Last Visit
1 January 2023

Study Director

dr. J. Schaap

Cardioloog

Office Contact

S. Jansen

Studiemanager

The page has expired.